Could HLA-type be the answer to individual differences in COVID-19 severity?
Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments
Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments
Advance your biopharma research through HPLC with this first-of-its-kind application-focused resource
ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community
The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years
The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market
Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse
Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing
Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection
New kit enables researchers to generate more data in less time to support viral vector bioprocess analytics
Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva